Last reviewed · How we verify
NCT04038164
Dog-Assisted Therapy for Children and Adolescents With FASD
NA trial testing Dog-Assisted Therapy and pharmacological treatment in FASD in 39 participants. Completed in 2 April 2019.
2 April 2019
Quick facts
| Lead sponsor | Hospital Universitari Vall d'Hebron Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 39 |
| Start date | 2 April 2018 |
| Primary completion | 2 April 2019 |
| Estimated completion | 2 April 2019 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Dog-Assisted Therapy and pharmacological treatment
Conditions studied
- FASD — all drugs for FASD →
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Who can join
Adults 6 to 18, any sex, with FASD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The rationale of the present study was to evaluate the efficacy of DAT in children and adolescents with FASD in relation to its effects on social skills, internalized and externalized symptomatology and on severity of FASD symptoms. This objective was accomplished through a randomized controlled pilot study of DAT for children and adolescents with FASD.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Dog-Assisted Therapy for Children and Adolescents With Fetal Alcohol Spectrum Disorders a Randomized Controlled Pilot Study.
Vidal R, Vidal L, Ristol F, Domènec E, et al · · 2020 · cited 5× · PMID 32528389 · DOI 10.3389/fpsyg.2020.01080 -
Dog-Assisted Therapy vs Relaxation for Children and Adolescents with Fetal Alcohol Spectrum Disorder: A Randomized Controlled Study.
Vidal R, Vidal L, Lugo J, Ristol F, et al · · 2024 · cited 3× · PMID 37340213 · DOI 10.1007/s10803-023-06023-5
Verify or expand the search:
- PubMed search for NCT04038164
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospital Universitari Vall d'Hebron Research Institute trials
Trials by the same sponsor.
- NCT07519343 — Migraine and Endometriosis: The FEMININE Study · not yet recruiting
- NCT07509541 — Hemodynamic and Respiratory Instability During Percutaneous Pulmonary Thrombectomy · not yet recruiting
- NCT07456280 — Evaluation of the Non-invasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With · NA · not yet recruiting
- NCT07281911 — Early Biological and Mechanical Profiling in Sepsis-Associated ARDS · not yet recruiting
- NCT07430501 — Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatme · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04038164 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitari Vall d'Hebron Research Institute
- Last refreshed: 30 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04038164.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing